» Articles » PMID: 32496252

An Epidemiological Study of Laboratory Confirmed COVID-19 Cases Admitted in a Tertiary Care Hospital of Pune, Maharashtra

Overview
Specialty Public Health
Date 2020 Jun 5
PMID 32496252
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: India has reported more than 70,000 cases and 2000 deaths. Pune is the second city in the Maharashtra state after Mumbai to breach the 1000 cases. Total deaths reported from Pune were 158 with a mortality of 5.7%. To plan health services, it is important to learn lessons from early stage of the outbreak on course of the disease in a hospital setting.

Objectives: To describe the epidemiological characteristics of the outbreak of COVID-19 in India from a tertiary care hospital.

Methods: This was a hospital-based cross-sectional study which included all admitted laboratory confirmed COVID19 cases from March 31, to April 24, 2020. The information was collected in a predesigned pro forma which included sociodemographic data, duration of stay, family background, outcome, etc., by trained staff after ethics approval. Epi Info7 was used for data analysis.

Results: Out of the total 197 cases, majority cases were between the ages of 31-60 years with slight male preponderance. Majority of these cases were from the slums. Breathlessness was the main presenting symptom followed by fever and cough. More than 1/5 of patients were asymptomatic from exposure to admission. The case fatality rate among the admitted cases was 29.4%. Comorbidity was one of the significant risk factors for the progression of disease and death (odds ratio [OR] = 16.8, 95% confidence interval [CI] = 7.0 - 40.1, P < 0.0001).

Conclusion: Mortality was higher than the national average of 3.2%; comorbidity was associated with bad prognosis.

Citing Articles

A cross-sectional study to assess the prevalence of anosmia and ageusia and its association with disease severity among COVID-19 affected patients in Salem, Tamil Nadu.

Rajamani S, Ranganathan R, Kanaguraju K, Shanmugaraja K J Family Med Prim Care. 2022; 11(6):2340-2344.

PMID: 36119305 PMC: 9480714. DOI: 10.4103/jfmpc.jfmpc_1308_21.


Clinico-epidemiological profile and outcomes of adults with COVID-19: A hospital-based retrospective study in Kerala, India.

Anand M, Mini G, Bobby M, Anilkumar A, Kamala S, Kutty L J Family Med Prim Care. 2022; 11(6):3000-3005.

PMID: 36119227 PMC: 9480700. DOI: 10.4103/jfmpc.jfmpc_2273_21.


Randomised trial to determine the effect of vitamin D and zinc supplementation for improving treatment outcomes among patients with COVID-19 in India: trial protocol.

Sharma K, Partap U, Mistry N, Marathe Y, Wang M, Shaikh S BMJ Open. 2022; 12(8):e061301.

PMID: 36038172 PMC: 9437735. DOI: 10.1136/bmjopen-2022-061301.


Prevalence of co-morbidities and its association with mortality in Indian patients with COVID-19: A meta-analysis.

Jindal R, Gupta M, Khan F, Chaudhry G Indian J Anaesth. 2022; 66(6):399-418.

PMID: 35903589 PMC: 9316668. DOI: 10.4103/ija.ija_845_21.


Factors associated with differential COVID-19 mortality rates in the SEAR nations: a narrative review.

Mulchandani R, Babu G, Kaur A, Singh R, Lyngdoh T IJID Reg. 2022; 3:54-67.

PMID: 35720145 PMC: 8882069. DOI: 10.1016/j.ijregi.2022.02.010.